techwiki
cell-based-immunotherapycancer-treatmentbiotechnology-researchtherapeutic-developmentllms.txt

ERC, Epitopoietic Research Corporation,

ERC develops patented cell-based immunotherapy treatments that stimulate the patient's immune system against tumors using autologous and allogeneic tumor cell lysates.

ERC uses a unique patented approach to treat tumours by directly stimulating the patient's immune system. The company's technology employs whole cells and lysates derived from autologous and allogeneic tumor cells as the basis for its immunotherapy treatments.